Calgon spent $2M on CEO pay in ’12
By Thomas Olson
Published: Thursday, March 21, 2013, 12:01 a.m.
Updated: Thursday, March 21, 2013
Calgon Carbon Corp. paid its chief executive and its former CEO a combined total of $2 million last year, according to proxy materials.
The Robinson company, which produces air and water purification systems, paid CEO Randy Dearth $769,613, including a salary of $222,708. Dearth joined Calgon Carbon in August after serving as CEO of Lanxess Corp., the chemicals company based in Findlay. The filing also said he would receive $1.4 million if there's a change in control of the company.
Former CEO John Stanik, who retired in July, received total compensation of $1.2 million, including a salary of $320,833. He received $1.3 million in total pay in 2011, including $545,113 in salary.
Stanik forfeited his performance-based stock grants and unvested stock options granted in the last two years as part of his separation agreement.
The company will hold its annual shareholders meeting May 1 at 1 p.m. at the headquarters in Robinson.
At the meeting, management will recommend four nominees to its board, including two independent nominees agreed upon with a dissident shareholder on March 12. Starboard Value LP, a New York investment firm with a 9.2 percent stake in the company, initially had sought to elect three nominees to Calgon Carbon's board.
Management agreed to support one of Starboard's nominees, Louis Massimo, former executive vice president and chief operating officer of Arch Chemicals Inc., and one nominee suggested by the board, Donald Templin, senior vice president and chief financial officer of Marathon Petroleum Corp.
Thomas Olson is a staff writer for Trib Total Media. He can be reached a 412-320-7854 or at firstname.lastname@example.org.There are currently no comments for this story.
- FedEx 4Q profit drops as economic growth is weak
- Fed suggests it’s closer to slowing bond purchases
- Highmark to extend self-insurance plans to small businesses
- SEC investigation to continue into ‘suspicious’ acquisition of Heinz stock option
- It’s about what you can bring
- PNC to phase out free checking accounts
- Merck, Pfizer sue to block proposed version of AzaSite
- More choose to buy into jobs
- Molecular differences in cancers found in UPMC’s ‘big data’ results
- Pending FDA approval, trials to begin on ALung’s artificial lung
- Wealthy carry weight around with highly prestigious, metal credit cards